{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Open-label+Abatacept", "query": { "intervention": "Open-label Abatacept" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 60, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Open-label+Abatacept&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T13:19:53.095Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01279954", "title": "Abatacept in the Treatment of Uveitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uveitis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Oregon Health and Science University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 10, "start_date": "2012-01", "completion_date": "2017-06", "has_results": true, "last_update_posted_date": "2019-02-21", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01279954" }, { "nct_id": "NCT00578448", "title": "Belatacept Pharmacokinetic Trial in Renal Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Renal Transplantation" ], "interventions": [ { "name": "Belatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 14, "start_date": "2008-03", "completion_date": "2012-09", "has_results": true, "last_update_posted_date": "2014-01-17", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 2, "location_summary": "Springfield, Massachusetts • Detriot, Michigan", "locations": [ { "city": "Springfield", "state": "Massachusetts" }, { "city": "Detriot", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00578448" }, { "nct_id": "NCT04186871", "title": "Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autoimmune Disorder", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Primary Sjögren's Syndrome" ], "interventions": [ { "name": "branebrutinib", "type": "DRUG" }, { "name": "abatacept", "type": "DRUG" }, { "name": "branebrutinib placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 119, "start_date": "2020-01-07", "completion_date": "2022-12-05", "has_results": true, "last_update_posted_date": "2024-01-16", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 40, "location_summary": "Phoenix, Arizona • Covina, California • Encino, California + 35 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Covina", "state": "California" }, { "city": "Encino", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04186871" }, { "nct_id": "NCT07675174", "title": "Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "GVHD - Graft-Versus-Host Disease" ], "interventions": [ { "name": "Post transplant cyclophosphamide, bortezomib and sitagliptin in 3+3 design to MTD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Northwell Health", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2026-07-01", "completion_date": "2032-07-01", "has_results": false, "last_update_posted_date": "2026-06-30", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 1, "location_summary": "New Hyde Park, New York", "locations": [ { "city": "New Hyde Park", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07675174" }, { "nct_id": "NCT00035555", "title": "Study Comparing the Safety and Efficacy of Belatacept With That of Cyclosporine in Patients With a Transplanted Kidney", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Rejection", "Kidney Transplantation", "Renal Transplantation" ], "interventions": [ { "name": "Belatacept", "type": "DRUG" }, { "name": "Cyclosporine", "type": "DRUG" }, { "name": "Mycophenolate mofetil (MMF)", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 230, "start_date": "2001-03", "completion_date": "2012-07", "has_results": true, "last_update_posted_date": "2014-01-13", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 12, "location_summary": "San Francisco, California • Atlanta, Georgia • Baltimore, Maryland + 9 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00035555" }, { "nct_id": "NCT00410410", "title": "A Study of Abatacept in Patients With Active Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "abatacept (ABA)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 591, "start_date": "2006-12", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-03-24", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00410410" }, { "nct_id": "NCT04877288", "title": "A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Renal Allograft Recipients" ], "interventions": [ { "name": "Belatacept", "type": "BIOLOGICAL" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Cyclosporine A", "type": "DRUG" }, { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Enteric Coated Mycophenolate Sodium", "type": "DRUG" }, { "name": "Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 102, "start_date": "2021-07-21", "completion_date": "2034-06-30", "has_results": false, "last_update_posted_date": "2026-08-31", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04877288" }, { "nct_id": "NCT01844518", "title": "Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Active Polyarticular Juvenile Idiopathic Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 219, "start_date": "2013-08-30", "completion_date": "2023-02-01", "has_results": true, "last_update_posted_date": "2023-07-12", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Hartford, Connecticut + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01844518" }, { "nct_id": "NCT00095147", "title": "Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept (ABA) + Methotrexate (MTX), double-blind (DB)", "type": "DRUG" }, { "name": "Infliximab (INF) + MTX, DB", "type": "DRUG" }, { "name": "Placebo (PLA) + MTX, DB", "type": "DRUG" }, { "name": "PLA + MTX switched to ABA+ MTX, DB", "type": "DRUG" }, { "name": "ABA, open-label (OL)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 431, "start_date": "2005-02", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2015-03-24", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 19, "location_summary": "Huntsville, Alabama • Denver, Colorado • Boca Raton, Florida + 16 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Denver", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Largo", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00095147" }, { "nct_id": "NCT00048932", "title": "A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Double-blind Abatacept", "type": "DRUG" }, { "name": "Double-blind Placebo", "type": "DRUG" }, { "name": "Open-label Abatacept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1795, "start_date": "2002-12", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2011-11-24", "last_synced_at": "2026-09-04T13:19:53.095Z", "location_count": 44, "location_summary": "Decatur, Alabama • Paradise, Arizona • Phoenix, Arizona + 41 more", "locations": [ { "city": "Decatur", "state": "Alabama" }, { "city": "Paradise", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00048932" } ] }